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Acanthamoeba castellanii is a free-living protozoan pathogen capable of causing a blinding keratitis and
fatal granulomatous encephalitis. Current treatment generally involves an hourly application of poly-
hexamethylene biguanide (PHMB) over a period of several days but this is not entirely effective against
all strains/isolates. The tolerance mechanisms of PHMB in Acanthamoeba cells remain unclear. In this
study, we found that the mRNA expression level of disulﬁdeisomerase domain containing protein (PDI)
increased rapidly in surviving cells of the highly PHMB-tolerant Acanthamoeba castellanii strain, NCKH_D,
during PHMB treatment, but not in the ATCC standard strain. After PDI-speciﬁc silencing, NCKH_D was
found to be more vulnerable to PHMB treatment. The results described above show that PDI is an
important gene for PHMB tolerance ability in a highly PHMB-tolerant strain of Acanthamoeba and pro-
vide a new insight for more efﬁcient medicine development for Acanthamoeba keratitis.
© 2016 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Acanthamoeba keratitis (AK) is a very painful, serious corneal
infection caused by free-living pathogenic protozoans of the genus
Acanthamoeba (McCulley et al., 1995; Visvesvara et al., 2007).
Acanthamoeba species are ubiquitous, free-living protozoa that
exist as motile trophozoites and dormant cysts in many environ-
ments, including swimming pools, hot tubs, lakes, soil, dust and
drinking fountains (Brown et al., 1982). The trophozoite stage of
Acanthamoeba feeds on organic particles and microbes and divides
mitotically under optimal condition. With exposure to harsh con-
ditions or during a period of stress, the cells can be transformed
into double-walled cysts. The inner wall of the cyst possesses cel-
lulose and the outer wall consists of proteins and polysaccharides.y, College of Medicine,
ad, Tainan City, 701, Taiwan.
. Lin).
Ltd on behalf of Australian Society fDuring encystation, the largest increases in resistance are observed.
An increasing number of cases of severe ocular inﬂammation
and visual loss have been caused by Acanthamoeba infection in the
past two decades. This increased prevalence has been linked to the
increasing use of contact lenses (Brown et al., 1982; Broxton et al.,
1983; Auran et al., 1987; Allen et al., 2004). Clinical cases of AK
are largely restricted to contact lens wearers who have experienced
some sort of trauma to their corneal epithelium (CDC,1987; Paszko-
Kolva et al., 1991; van Klink et al., 1993; Morlet et al., 1997). Due to
difﬁculty in early diagnosis and poor response to most antibiotics,
therapeutic penetrating keratoplasty is often used to try to eradi-
cate the pathogen in uncontrolled disease. If it is not diagnosed
early and treated aggressively, extensive ocular damage include a
ring-like corneal inﬁltrate, epithelial destruction, and dispropor-
tionately severe ocular pain, could occur and enucleation may be
required (Auran et al., 1987).
The ﬁrst two AK cases in Taiwan were reported in 1988, corneal
biopsy yielded conﬁrmative diagnosis (Chan and Chan, 1988).
Medical records reviewed by all patients with clinically diagnosed
microbial keratitis presenting at the National Taiwan Universityor Parasitology. This is an open access article under the CC BY-NC-ND license (http://
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of cases of microbial keratitis were caused by Acanthamoeba species
(Fong et al., 2004). Currently, the treatment regimen in Taiwan
involves hourly drug applications for prolonged periods (Gray et al.,
1994; McDonnell and Russell, 1999; Visvesvara et al., 2007). Of
these drugs, PHMB is a membrane-active agent with broad-
spectrum antimicrobial efﬁcacy that has been used as an anti-
septic in infective keratitis (Gray et al., 1994; McDonnell and
Russell, 1999; Donoso et al., 2002; Narasimhan et al., 2002),
swimming pool sanitization, and the treatment of cooling systems
(Kusnetsov et al., 1997). Preparations of PHMB are mixtures of
polymeric biguanides with an approximatemolecular weight range
of 400e8000. The structure of PHMB is as follows: [e(CH2)
6.NH.C(]NH).NH.C(]NH).NHe]n, where n ¼ 2e40, with an
approximate molecular weight range of 400e8000. In previous
studies on prokaryotic cells, PHMB was shown to interact with
cytoplasmic membranes to cause lethal action, nonspeciﬁc alter-
ations in membrane integrity, loss of LPS, and loss of function in
membrane proteins (Broxton et al., 1983, 1984; Gilbert et al., 1990).
PHMB has also been shown to interfere with prokaryotic cell
functions by binding to nucleotides (Allen et al., 2004), and Chin-
dera et al. observed that PHMB not only disrupt the microbial
membrane but also arrests cell division and the condensation of
chromosomes in treated bacteria species (Chindera et al., 2016).
PHMB is further believed to cause the production of large
quantities of phosphorus, which accumulate in the nuclei of
A. castellanii cells as a result of reduced permeability and protein
coagulation or the aggregation of phospholipids (Khunkitti et al.,
1999). Trophozoites have been reported to absorb more bigua-
nides than do cysts. Complex PHMB-nucleotide formations have
been observed near the cell wall and nuclei following drug uptake
by Acanthamoeba. Nonetheless, clinical outcomes tend to be poor,
particularly in cases involving drug-resistant/tolerant strains. The
mechanism underlying the resistance to PHMB by Acanthamoeba
cells has yet to be elucidated for overcoming infection caused by
these PHMB-resistant/tolerant strains.
To gain a deeper understanding of the mechanism underlying
the ﬁrst step of resistance to PHMB in Acanthamoeba, we estab-
lished an RNA-seq database for Acanthamoeba, including the non-
pathogenic ATCC strain and the highly PHMB-tolerant Acantha-
moeba castellanii strain, NCKH_D (Huang et al., 2015). In our pre-
vious study, we have shown that A. castellanii clinical isolates
NCKH_B and NCKH_D have higher tolerance toward PHMB than
does the standard strain, ATCC 30010 (Huang et al., 2015). These
two isolates differ in their response to PHMB stress: NCKH_B
transforms into a pseudocyst to escape the drug, but NCKH_D does
not. Especially, NCKH_D is collected from the combinational drug
therapy failed patient. Therefore, NCKH_D utilized an alternative
drug tolerance strategy rather than transform into pseudocyst/cyst.
In this study, we try to reveal the molecular mechanism of the
PHMB resistance in NCKH_D trophozoites. Furthermore, we found
that the mRNA expression level of the disulﬁdeisomerase domain
containing protein (PDI) had risen rapidly in surviving cells of the
NCKH_D strain but not in the ATCC standard strain during PHMB
treatment. After PDI-speciﬁc silencing, NCKH_D was found to be
more vulnerable to PHMB treatment. The results of this study will
help to characterize the potential PHMB resistance mechanisms of
Acanthamoeba and will aid in the development of a more effective
treatment regimen for AK.
2. Materials and methods
2.1. Culture of Acanthamoeba protozoa
Acanthamoeba species are axenically cultured in a proteasepeptone-yeast extract-glucose (PYG) medium, pH 6.5, at 28 C in
cell culture ﬂasks. Trophozoites are harvested at the logarithmic
growth phase after cultivation for 3e5 days. The clinical isolates
were isolated from the corneal ulcers of patients who were diag-
nosed with AK in the Cheng Kung University Hospital (Li et al.,
2012), including the high PHMB tolerance pathogenic Acantha-
moeba castellanii isolates NCKU_D which is used in this study
(Huang et al., 2015).
2.2. Growth curves and survival rate
Detached cells will be centrifuged and the pellet will be sus-
pended in a 0.5% trypan blue solution in sterile PBS for 1 min. Cells
will be then counted in a Neubauer hemocytometer chamber, and
the stained cells will be considered dead. Cell counting will be
performed under a light microscope in the duration to get the
numbers of alive and dead cells which will be differentiated with
trypan blue dye exclusion viability method. The number of stained
cells will be subtracted from the total, indicating the death ratio in
each interaction condition and time.
2.3. Drug treatment
PHMB will be preparation in different concentration in Page's
amoeba saline (PAS). To further clarify the appropriate amount of
cells, drug concentration and duration of drug experiment; we will
add the counted cells in drug solution and shake by 100 rpm.
2.4. Total RNA isolation and cDNA synthesis
We collected the RNA samples from the non-pathogenic isolate
ATCC 30010 and the pathogenic Acanthamoeba castellanii isolates
NCKU_D trophozoites. Pellet the cells by centrifugation, lyse the
pellet of Acanthamoebawith TRIzol®(Invitrogen), add 100% Ethanol
(Merck) as 1:1 vol, mix it well by vortexing. Extract the RNA by
Direct-zol™ RNA MiniPrep kit (Zymo Research). RNA was stored
at 70 C. The entire concentration and A260/A280 ratio of mRNA
were measured with ND-1000 (NanoDrop). High Capacity cDNA
Reverse Transcription Kits (Applied Biosystems) were used in this
study.
2.5. High-throughput RNA sequence reads collection
The RNA samples from the untreated/PHMB treated A. castellanii
ATCC 30010 and clinical isolates NCKH_D were used for generating
sequence reads with Illumina platform, by which more than 21
million of sequence reads. The samples were also used for reverse
transcription PCR validation.
2.6. Reverse transcription PCR
One-step reverse transcription PCR was performed with Su-
perScript™ One-Step RT-PCRwith Platinum® Taq kit (Invitrogen) to
investigate the gene expression of Acanthamoeba. All of the cDNA
was synthesized from 1 mg of total RNA of Acanthamoeba. RT-PCR
products were separated on the EtBr-stained gel after electropho-
resis in 1.0e1.2% agarose. Primers were listed in Table 1.
2.7. Gene silencing methodology
Small interfering RNA (siRNA) targeting on the 1265th to 1283rd
nucleotide in the exon coding region of the PDI (ACA1_189420)
gene of Acanthamoeba was designed and synthesized by Dharma-
con (GE Healthcare Dharmacon Inc.), based on the cDNA sequence
of the PDI gene. The sense and the antisense sequences are
Table 2
Differential gene expression statistics from RNA-Seq.
Effective transcripts DE transcriptsa
30010 non-treat VS treated PHMB 3HR 13,642 71 0.47%
D, non-treat VS treated PHMB 3HR 12,139 525 3.50%
D vs 30010, non-treat 13,583 3260 21.76%
Total references 14,980 (FDR  0.05)
a The effective transcripts deﬁned as the count sum of two libraries for a tran-
script 1.
Table 1
Primer list used for PCR and reverse transcription PCR reactions.
Target region Primers name Primer sequence (50 e 30) Amplicon (bp)
18s rDNA AcantF900 CCCAGATCGTTTACCGTGAA 180 Qvarnstrom et al., 2006
AcantR1100 TAAATATTAATGCCCCCAACTATCC
PDI gene
ACA1_189420
ACTTCGATGAGCACACTGCC 641
AACGCCAGAGTAGTCCCTCA
PDI gene
ACA1_374120
CAAGGCCGACCTCTTTGACT 621
CTGCCGAGCTCATAGTCCTG
PDI gene
ACA1_374090
GACGTGTGGAACCCCATCAA 449
TTGTCATTGTCCGCGAAACG
PDI gene
ACA1_149830
TCGAAGACTTCACCGCCTTC 481
AGCTCGTCCTTCTTTTCGGG
TrXR
ACA1_398900
AGTACACAGAATGGTCATCGT 681bp
TTGATCTTGAGGCCTGTGAC
Fig. 1. The expression level of PDI genes in clinical isolate NCKH_D and ATCC 30010 with
rRNA expression is used as a control. (D) Functional domain prediction of PDI gene, ACA1_
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CUUGGUU. The siRNA was transfected to Acanthamoeba tropho-
zoites as described in a previous study (Kong and Pollard, 2002). As
a negative control, siRNA with a scrambled sequence (Dharmacon)
absent in Acanthamoeba was used.
3. Results
To characterize the potential PHMB resistance mechanisms ofor without PHMB treatment. (A) and (C) Reverse transcription PCR analysis. The 18S
189420.
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isolated the clinical strains NCKH_D with high PHMB tolerance and
created the platforms for screening and elucidating the efﬁcacy of
treatment (Huang et al., 2015). To conﬁrm that NCKH_D does not
depend on transforming to a cyst to escape the drug, we used a
differential interference contrast microscope to observe the
morphology of NCKH_D. The result clearly indicates that NCKH_D
did not transform to cyst during the 6 h PHMB treatment (Video 1).
We proposed that Acanthamoeba could produce the stress proteins
and regulate certain genes for responding to PHMB treatments. In
this study, we established the RNA datasets of strains including
NCKH_D and the standard strain, ATCC 30010, for examining the
genes associated with PHMB resistance.
Supplementary video related to this article can be found at
http://dx.doi.org/10.1016/j.ijpddr.2016.11.001.
3.1. The discovery of PDI by comparative analysis of RNA-seq
We analysed the RNA-seq data which were collected from
treated and non-treated Acanthamoeba cells, with the software
package edgeR (empirical analysis of DGE in R), which is part of the
Bioconductor project (Gentleman et al., 2004; Robinson et al.,
2010). The differential gene expression results from the compara-
tive analysis are shown in Table 2. After combining the differentialFig. 2. The expression level of thioredoxindisulﬁde reductase in clinical isolate NCKH_D
PCR analysis. The 18S rRNA expression is used as a control.gene expression results from RNA-seq databases, we noticed that a
special gene, the disulﬁdeisomerase domain containing protein
(PDI, ACA1_189420), is up-regulated during PHMB treatment in
NCKH_D but down-regulated during PHMB treatment in ATCC
30010.
3.2. The validation of PDI expression
From the comparative analysis of RNA-seq, we found that not
only one isoform of PDIs, ACA1_189420, is upregulated during the
PHMB-treated experiments but also three isoforms of PDI in the
NCBI gene database, including ACA1_149830, ACA1_374090, and
ACA1_374120, were up-regulated. To conﬁrm the expression pat-
terns of the PDI isoforms we analysed the RNA samples which were
not only previous samples for establishing the database but also
those repeated by reverse transcription PCR. The transcriptional
expression patterns of the PDI proteins are shown in Fig. 1A and the
quantiﬁed the expression patterns of ACA1_189420 are shown in
Fig. 1B. Only the ACA1_189420 in surviving cells of the NCKH_D, a
highly PHMB-tolerated isolate strain associated with keratitis
infection, increased rapidly compared to the ATCC standard strain,
and the three other A. castellanii isolates, NCKH_A, C, and P, which
were collected from patients with PHMB treatment successes
(Fig. 1C).and ATCC 30010 with or without PHMB treatment. (A) and (B) Reverse transcription
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To understand the functions of PDI ACA1_189420, we predicted
its functional domains via the NCBI Conserved Domain Search
website (http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi).
From the analysed prediction, there are two Thioredoxin-like su-
perfamily domains in ACA1_189420 (Fig. 1D). Thioredoxins are
proteins that act as antioxidants. Therefore, we proposed that PDI
(ACA1_189420) may be involved in oxidative protein folding in the
endoplasmic reticulum by acting as a catalyst and folding assistant.
3.4. The expression level of thioredoxindisulﬁde reductase
(ACA1_398900) does not change during PHMB treatment
The proteins that act as antioxidants are usually maintained in
their reduced form at steady state. So we were curious about the
expression pattern of Thioredoxindisulﬁde reductase
(ACA1_398900), which is the enzyme used to reduce Thioredox-
indisulﬁde in Acanthamoebal cells during the PHMB treatment.
From the results shown in Fig. 2A and B, the transcriptional
expression level of ACA1_398900 does not change after PHMB
treatment.
3.5. PDI (ACA1_189420) is important for NCKH_D PHMB tolerance
ability
For elucidating the importance of PDI ACA1_189420 in the
PHMB tolerance of NCKH_D, we knocked down the gene expression
and used the PHMB treatment again. After PDI ACA1_189420-
speciﬁc siRNA treatment, we found NCKH_D to be more vulner-
able to PHMB (Fig. 3). The result revealed that PDI is an important
gene for the PHMB tolerance ability.
3.6. PDI is not a general stress protein
To prove that ACA1_189420 is a general stress or a PHMB spe-
ciﬁc induced response protein, we tested physical and chemical
stresses, such as heat shock and H2O2 treatments.
In heat shock experiments, we found that NCKH_D is more
tolerant to high-temperature treatment than the ATCC standard
strain 30010 (Fig. 4A). These results indicate that the PDIFig. 3. Effects of ACA1_189420 silencing in the NCKH_D strain during the progress
of PHMB treatment. **, the means are signiﬁcantly different at a P value of <0.01; *,
the means are signiﬁcantly different at a P value of <0.05 by Student's t-test.(ACA1_189420) expression of 30010 and NCKH_D is both down-
regulated, which means PDI is not important for the high-
temperature tolerance ability of NCKH_D (Fig. 4B). In H2O2 treat-
ment experiments, NCKH_D was also more tolerant to hydrogen
peroxide treatment than 30010, but the PDI expression of NCKH_D
had no speciﬁc change (Fig. 5A and B). Thus, we have shown that
PDI (ACA1_189420) is a PHMB induced stress protein but not a
general stress protein.4. Discussion
The broad-spectrum antimicrobial polymer PHMB kills bacteria,
fungi, parasites and certain viruses. Presently, AK treatment in-
volves hourly applications of PHMB over a prolonged period;
however, even this aggressive approach is unable to ensure any-
thing other than a poor prognosis. Further, the treatment is not
entirely effective against all strains/isolates. Our previous work
presented a PHMB highly tolerant isolate, NCKH_D, which does not
depend on transforming to a cyst to escape the drug (Huang et al.,
2015). However, the action and resistance mechanisms of PHMB in
Acanthamoeba cells are still not clear. Knowledge of these mecha-
nisms could be used to progress the current treatment for more
effective use against the infection.
Based on the experimental results of the present study, we have
for the ﬁrst time provided solid evidence that PDI (ACA1_189420) is
a PHMB resistance associated gene in Acanthamoeba. There are two
Thioredoxin-like superfamily domains in PDI (ACA1_189420). Thi-
oredoxin (Trx), an important factor for protein dithiol/disulﬁde
homeostasis and is conserved from bacteria to man. However, theFig. 4. Effects of the Acanthamoeba strains during the heat shock treatment. (A)
Survival rate of Acanthamoeba strains during the 40 C shock. (B) Reverse transcription
PCR analysis of the PDI gene, ACA1_189420, expression level in clinical isolate NCKH_D
and ATCC 30010 with or without 40 C heat shock. The 18S rRNA expression is used as
a control.
Fig. 5. The expression level of ACA1_189420 in Acanthamoeba strains during the H2O2 treatment. (A) The light observation for effect imaging of the addition of H2O2 to the live
Acanthamoeba strains. (B) Reverse transcription PCR analysis of the PDI gene, ACA1_189420, expression level in clinical isolate NCKH_D and ATCC 30010 with or without H2O2
treatment. The 18S rRNA expression is used as a control.
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understood in Acanthamoeba. In other protists, there are alternative
factors in the Trx system that have been reported as drug targets for
parasites. In 2007, Leitsch et al. found that the anti-oxidative
enzyme, TrxR, could reduce metronidazole and other nitro com-
pounds in Entamoeba histolytica (Leitsch et al., 2007). TrxR has also
been found to reduce metronidazole and other nitro-heterocyclic
drugs in Trichomonas vaginalis (Leitsch et al., 2009). In Giardia
lamblia, TrxR has been suggested to assist as a drug target (Leitsch
et al., 2016).
In this study, we have elucidated the associated gene and
possible mechanism of PHMB resistance, as described here with a
highly PHMB-tolerant strain of Acanthamoeba. This study also
provides novel insight for dissecting the PHMB resistant mecha-
nisms in Acanthamoeba and possible improvements for PHMB
treatment of Acanthamoeba keratitis.5. Conclusion
These results described above show that PDI (ACA1_189420) is
an important gene for PHMB tolerance ability in highly PHMB-
tolerant Acanthamoeba.Conﬂicts of interest
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